Company

QuantumCell ApS

QuantumCell uses AI and quantum computing to develop therapeutics for neuropsychiatric disorders.

About

Founded in 2025, QuantumCell develops an AI-native, quantum-enabled platform for neuropsychiatric therapeutics. It works with healthcare providers, researchers, and institutions. The company is based in Frederiksberg, Denmark. In July 2026, it raised DKK 117.5 million from Forbion, Lundbeckfond Ventures, Novo Holdings, and EIFO.

1Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in